Anti-Human Apo AII

CR06 is a polyclonal antibody targeting human Apolipoprotein A-II (APOA2), the second most abundant protein component of high-density lipoprotein (HDL). Validated for ELISA, Western blot, and immunodiffusion applications in human plasma lipoprotein research, CR06 enables quantification and characterization of APOA2-containing HDL particles.